News

According to Vein Clinics of America (VCA), the Ohio office represents its 33rd location in the US and offers the latest in vein disease diagnosis and treatment. Ted

Andrew Whelan, CEO of BioElectronics, said: “This is significant news for BioElectronics. We were already seeing strong success with London drugs in Western Canada and we have recently

Dr Groth is also president and CEO of Ascent Private Equity, the general partner of the funds, which are focused on investments in medical device, life science and

Biotage currently has two internal production units. The majority of the consumables Biotage offers its customers are manufactured at the company’s factory in Cardiff, Wales. The Charlottesville, VA

Simon Ainley of Walker Ainley Associates will remain as a consultant to the company to ensure an orderly handover of responsibilities to Mr Miscampbell. Also, Lothar Nau and

Fiscal 2009 guidance reaffirmed For the fiscal year ending September 30, 2009, management expects net sales to be in the range of $151 million to $156 million and

Baxter reported fourth quarter net income of $569 million, an increase of 19%from the $478 million reported in the fourth quarter of 2007. Earnings per diluted share of

The UK Medicines and Healthcare Products Regulatory Agency’s approval for the trial has been given subject to provision of data both from an ongoing preclinical study and from

This cost-cutting initiative includes the elimination of more than 900 open positions. The approximately 600 associates affected by the layoff will receive both severance pay and outplacement assistance